Literature DB >> 9331199

Orbital compression syndrome in sickle cell disease.

E L Curran1, J C Fleming, K Rice, W C Wang.   

Abstract

BACKGROUND: Orbital complications are an uncommonly reported finding in sickle cell disease.
METHODS: The authors review the reported orbital manifestations of sickle cell disease and discuss a patient with hemoglobin sickle beta(0) thalassemia in whom rapidly progressive bilateral orbital compression developed.
RESULTS: Computed tomography of the orbits in a patient with fever, headache, orbital swelling, and optic nerve dysfunction displayed bilateral superior subperiosteal cystic masses. Surgical exploration showed bilateral liquefied hematomas, which were evacuated. Recovery was complete 13 days after surgery. A mild recurrence 14 months later resolved with conservative treatment. The literature contains 11 reports of 16 young patients with sickle cell disease (15 sickle cell disease [Hb SS] and 1 hemoglobin sickle cell disease [Hb SC]) with rapidly developing findings ranging from frontal headache, fever, and eyelid edema to bilateral complete orbital compression syndrome. Including our patient, 60% had orbital hemorrhage on computed tomography. Ten of 12 patients tested were found to have orbital bone marrow infarctions. Sixteen of 17 patients had complete recovery; 13 were treated conservatively and 4 surgically. Only 2 of 17 had recurrence.
CONCLUSIONS: Orbital complications in sickle cell disease are unusual manifestations in which a vaso-occlusive process in the marrow space around the orbit results in frontal headache, fever, eyelid edema, and often orbital compression syndrome. Subperiosteal hematomas are common and appear to result from bone marrow infarctions. Appropriate management requires a thorough evaluation to exclude other hemorrhagic, infectious or neoplastic processes, as well as vigilant ophthalmic monitoring. Supportive care is effective, unless optic nerve dysfunction or large hematomas are present, which would indicate that surgical evacuation is warranted to prevent loss of vision and to speed recovery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9331199     DOI: 10.1016/s0161-6420(97)30088-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  "Sickle Cell Disease in the Emergency Department: Atypical Complications and Management"

Authors:  Amanda M Brandow; Robert Liem
Journal:  Clin Pediatr Emerg Med       Date:  2011-09-01

Review 2.  Headache and Facial Pain in Sickle Cell Disease.

Authors:  Angeliki Vgontzas; Larry Charleston; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2016-03

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

4.  Frontal Bone Infarctions Masquerading as Bilateral Orbital Cellulitis in a Patient with Sickle Cell Disease.

Authors:  Abdulaziz I Al Somali; Halah S Bin Helayel; Saeed A Jubran; Jumana T Hariri; Hala M Nassim Ali
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29

Review 5.  Orbital infarction syndrome after cerebral aneurysm surgery: A case series and literature review.

Authors:  Sung Won Choi; Kyung Tae Kang; Jong Hwa Jun; Ji Hye Jang; Yu Cheol Kim
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.